Exploiting the apicoplast: apicoplast-targeting drugs and malaria vaccine development
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Microbes and Infection
- Vol. 20 (9-10) , 477-483
Abstract
No abstract availableKeywords
Funding Information
- Australian Government Research Training Program (RTP) Scholarship
- Griffith University GLY Postgraduate Research Scholarship
- National Health and Medical Research Council (1037304)
This publication has 80 references indexed in Scilit:
- Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunityProceedings of the National Academy of Sciences, 2013
- Identifying apicoplast‐targeting antimalarials using high‐throughput compatible approachesThe FASEB Journal, 2011
- Redefining the role of de novo fatty acid synthesis in Plasmodium parasitesTrends in Parasitology, 2009
- Type II fatty acid synthesis is essential only for malaria parasite late liver stage developmentCellular Microbiology, 2009
- The Fatty Acid Biosynthesis Enzyme FabI Plays a Key Role in the Development of Liver-Stage Malarial ParasitesCell Host & Microbe, 2008
- Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challengeVaccine, 2008
- Multiple Antibiotics Exert Delayed Effects against the Plasmodium falciparum ApicoplastAntimicrobial Agents and Chemotherapy, 2007
- Inhibitors of Nonhousekeeping Functions of the Apicoplast Defy Delayed Death in Plasmodium falciparumAntimicrobial Agents and Chemotherapy, 2007
- Membrane transporters in the relict plastid of malaria parasitesProceedings of the National Academy of Sciences, 2006
- Genome sequence of the human malaria parasite Plasmodium falciparumNature, 2002